# S-1 and Irinotecan Combination Chemotherapy for Advanced Gastric Cancer

> **NCT00343668** · PHASE2 · UNKNOWN · sponsor: **Korean Cancer Study Group** · enrollment: 44 (estimated)

## Conditions studied

- Gastric Cancer

## Interventions

- **DRUG:** S-1, irinotecan

## Key facts

- **NCT ID:** NCT00343668
- **Lead sponsor:** Korean Cancer Study Group
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2005-09
- **Primary completion:** 2007-03
- **Final completion:** 2008-07
- **Target enrollment:** 44 (ESTIMATED)
- **Last updated:** 2010-05-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00343668

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00343668, "S-1 and Irinotecan Combination Chemotherapy for Advanced Gastric Cancer". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00343668. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*